Literature DB >> 498719

A method for studying drug metabolism in populations: racial differences in amobarbital metabolism.

W Kalow, B K Tang, D Kadar, L Endrenyi, F Y Chan.   

Abstract

The two main metabolites of amobarbital excreted in urine are 3'-hydroxyamobarbital (C-OH) and 1-(beta-D-glucopyranosyl) amobarbital (N-glu). When testing the metabolite ratio in small single samples of urine, it was found that the urine in a Caucasian population contained about one-third glucose conjugation and two-thirds hydroxylation product, while an Oriental population excreted both metabolites in equal proportion. Attempts to learn the causes for the different metabolite ratios led to an investigation of metabolite concentrations in urine. The sums of the average urinary concentration of C-OH was greater in Caucasians than in Orientals, no matter how the data were expressed; the reverse was true for the N-glu metabolite. C-OH data was scattered more widely among Orientals than Caucasians; this might indicate bimodality of the distribution curves. There also was a trend toward more N-glu metabolite in urine of females than of males. Measuring the metabolite/creatinine ratios narrowed the distribution range of the data, particularly after correction for sex difference in creatinine, but population differences were not changed. Expected relationships between metabolite content of urine, sampling times, and plasma half-life (t1/2) were established by calculation. A Caucasian female with no capacity for N-glucosidation was found during the first part of this population survey. An Oriental male with only trace capacity for amobarbital hydroxylation was found in the second part.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498719     DOI: 10.1002/cpt1979266766

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

1.  Stereochemical characterization of the diastereomers of the amobarbital N-glucosides excreted in human urine.

Authors:  W H Soine; P J Soine; F C Wireko; D J Abraham
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

3.  Comparative metabolism of mycophenolic acid by glucuronic acid and glucose conjugation in human, dog, and cat liver microsomes.

Authors:  J E Slovak; K Mealey; M H Court
Journal:  J Vet Pharmacol Ther       Date:  2016-06-15       Impact factor: 1.786

Review 4.  Pharmacogenetics and ecogenetics.

Authors:  D P Agarwal; H W Goedde
Journal:  Experientia       Date:  1986-10-15

5.  Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution.

Authors:  D B Jack
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

Review 7.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

8.  An assessment of short-cut procedures for studying drug metabolism in vivo using amobarbital as a model drug.

Authors:  B K Tang; W Kalow; L Endrenyi; F Y Chan
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.

Authors:  H H Zhou; Y P Chan; K Arnold; M Sun
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

10.  Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians.

Authors:  M Jurima; T Inaba; D Kadar; W Kalow
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.